Fig. 5.
Fig. 5. Failure-free survival according to molecular response status within the first year, 12-month landmark analysis. / (Molec. Responders, PCR-negative status after treatment; Molec. Nonresponders, PCR-positive status after treatment.)

Failure-free survival according to molecular response status within the first year, 12-month landmark analysis.

(Molec. Responders, PCR-negative status after treatment; Molec. Nonresponders, PCR-positive status after treatment.)

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal